系统性硬化症心肌炎具有独特的临床、组织学与预后特征:一项对比性组织学分析
该回顾性研究对比了系统性硬化症相关病毒阴性心肌炎(SSc-VNM)、孤立性VNM(i-VNM)及其他系统性自身免疫病相关VNM(a-VNM)的心内膜心肌活检资料,发现SSc-VNM患者心肌纤维化程度更高、心衰更常见且心脏相关死亡风险显著更高。
要点
- SSc-VNM患者心肌纤维化百分比及评分显著高于i-VNM和a-VNM。
- SSc-VNM患者就诊时呼吸困难分级更高,心衰仅见于SSc患者。
- SSc-VNM患者随访期间因心脏并发症死亡的比例显著更高。
核心结论
- SSc相关VNM具有独特的临床和组织学特征,表现为更常见的心衰、更高的呼吸困难分级和更重的心肌纤维化,并对应更差的心脏预后。
研究设计与样本
- 回顾性分析三组心内膜心肌活检证实的病毒阴性心肌炎队列:SSc-VNM 12例、孤立性VNM 12例、其他系统性自身免疫病相关VNM 10例。
- 心肌纤维化程度以相对百分比和纤维化评分(0-3)表示,基线及随访时收集临床数据、心肌酶、超声心动图、24小时动态心电图和心脏磁共振。
主要发现
- 心肌纤维化百分比:SSc-VNM 44.8(18.8)%,a-VNM 28.6(16.5)%,i-VNM 24.9(10.3)%,P=0.019。
- 心肌纤维化评分:SSc-VNM 2.3(0.8),a-VNM 1.4(1.1),i-VNM 1.2(0.7),P=0.002。
- SSc患者心肌纤维化与皮肤评分(r=0.625,P=0.03)及24小时动态心电图室性早搏数(r=0.756,P=0.01)直接相关。
- SSc-VNM患者就诊时呼吸困难分级更高(P=0.041),心衰仅见于SSc患者(25%)(P=0.05)。
- 心脏磁共振显示SSc-VNM患者心肌水肿几乎不可检出,与其他组相比P=0.02。
关键数值与推荐
- 随访期间因心脏并发症死亡的患者比例:SSc-VNM 50%,a-VNM 0%,i-VNM 8.3%,P=0.006。
- 随访期间死亡患者心肌纤维化程度更高:百分比52.2(11.6)% vs 27.5(12.9)%,P=0.024;纤维化评分2.83(0.41) vs 1.4(0.9),P<0.001。
- 所有患者均接受了免疫抑制治疗。
临床怎么用
- 对SSc患者出现心肌炎表现时应警惕其独特的高纤维化负荷和不良心脏预后,需加强心衰监测与随访。
- 心肌纤维化程度可能与皮肤评分及室性早搏负荷相关,提示SSc-VNM患者应关注皮肤病变活动及心律失常监测。
局限性
- 回顾性研究设计,样本量小(SSc-VNM 12例、i-VNM 12例、a-VNM 10例)。
- 原文未报告多变量校正分析,无法排除混杂因素对预后比较的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To outline the clinical, histological and prognostic features of systemic sclerosis (SSc) endomyocardial biopsy-proven myocarditis with respect to those of diverse endomyocardial biopsy-proven virus-negative myocarditis (VNM). METHODS: We retrospectively analysed data from three cohorts of endomyocardial biopsy-proven myocarditis: SSc-related VNM (SSc-VNM); isolated VNM (i-VNM); and VNM related to other systemic autoimmune diseases (a-VNM). The degree of myocardial fibrosis was expressed as relative percentage and fibrotic score (0-3). Clinical data, cardiac enzymes, echocardiogram, 24 h ECG Holter and cardiac magnetic resonance were obtained at baseline and during follow-up. Non-parametric tests were used. RESULTS: We enrolled 12 SSc-VNM [11 females, mean age 49.3 (14.2) years; seven diffuse-SSc, five early-SSc], 12 i-VNM [12 females, mean age 47.7 (10.8) years] and 10 a-VNM [four females, mean age 48.4 (16.3) years] patients. SSc patients had higher degrees of myocardial fibrosis as assessed by both percentage [SSc-VNM: 44.8 (18.8)%; a-VNM: 28.6 (16.5)%; i-VNM: 24.9 (10.3)%; P = 0.019] and score [SSc-VNM: 2.3 (0.8); a-VNM: 1.4 (1.1); i-VNM: 1.2 (0.7); P = 0.002]. Myocardial fibrosis directly correlated with skin score (r = 0.625, P = 0.03) and number of ventricular ectopic beats on 24 h ECG Holter in SSc patients (r = 0.756, P = 0.01). Dyspnoea class was higher at presentation in SSc-VNM patients (P = 0.041) and we found heart failure only in SSc patients (25%) (P = 0.05). At cardiac magnetic resonance, myocardial oedema was nearly undetectable in SSc-VNM patients compared with others (P = 0.02). All patients received immunosuppressive treatment. The number of patients who died during follow-up due to cardiac complications was significantly higher in SSc-VNM patients (50%), as compared with a-VNM (0%) and i-VNM (8.3%) patients (P = 0.006). Patients who died during follow-up had higher degrees of myocardial fibrosis [52.2 (11.6)% vs 27.5 (12.9)%, P = 0.024; fibrotic score: 2.83 (0.41) vs 1.4 (0.9), P < 0.001]. CONCLUSION: SSc has unique clinical and histological features, as it tends to present more frequently with heart failure and a higher dyspnoea class and to show higher degrees of myocardial fibrosis. These specific features are paralleled by a worse cardiac prognosis.
引用
- De Luca G, Campochiaro C, De Santis M, et al. Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis. Rheumatology (Oxford). 2020. PMID: 31990340. doi:10.1093/rheumatology/kez658
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。